BCL2L1 and neoplasm: We observed amplifications in chromosome arm 20q (chr20q) in 74/373 tumours (19.8%), which includes SRC, TOP1, BCL2L1, ZNF217, AURKA, GNAS and ARFRP1 (Fig. 2a).